Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "A"

News & Events

State-of-the-art cancer research equipment arrives in WA

A new state-of-the-art X-RAD radiation platform - the first of its kind in Australia - has arrived in WA, allowing WA cancer researchers to access cutting edge

News & Events

Youth Health report

Research for the Commissioner for Children & Young People seeking the views of >1,000 young people about their experiences accessing/using health services

Research

The relationship between school climate and mental and emotional wellbeing over the transition from primary to secondary school

The current study examined the relationship between students’ mental and emotional wellbeing and factors pertaining to school climate, focusing on the...

Research

CD4 allergen tetramers

The introduction of class II tetramers for identifying antigen-binding CD41 cells has lagged behind the use of class I tetramers because of difficulties...

News & Events

Dr Shaun Teo and Dr Paul Fournier awarded Diabetes Australia grants

A big congratulations to our The Kids and UWA researchers Dr Shaun Teo and Dr Paul Fournier who have both been awarded $70,000 grants for their diabetes research projects, under the 2023 Diabetes Australia Research Program (DARP).

News & Events

Farewell Tarini

After nearly two-and-a-half years in sunny Perth, Dr Tarini Chetty is headed back home to Scotland. Before she departs our shores.

Research

Meta-analysis of the neural correlates of vigilant attention in children and adolescents

Vigilant Attention (VA), defined as the ability to maintain attention to cognitively unchallenging activities over a prolonged period of time, is critical to support higher cognitive functions and many behaviours in our everyday life. Evidence has shown that VA rapidly improves throughout childhood and adolescence until young adulthood and tends to decline in older adulthood.

Research

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

Due to their anatomical locations, optic pathway gliomas (OPGs) can rarely be cured by resection. Given the importance of preserving visual function, we analyzed radiological and visual acuity (VA) outcomes for the type II RAF inhibitor tovorafenib in the OPG subgroup of the phase 2 FIREFLY-1 trial.

Research

Studies on the immunological mechanisms underlying progression versus resolution of asthma between adolescence and adulthood

This project seeks new information on asthma disease mechanisms, to help propel development of new and better anti-asthma drugs.